liveBook · Manning

Chemistry42

As explained in Build AI Drug Discovery Pipelines

Chemistry42 is a drug-design platform that generates and evaluates candidate molecular structures with multiple computational models.

Chemistry42 is a drug-design platform for generating and evaluating candidate molecules when conventional starting advantages—such as known selective compounds, a ligand-bound crystal structure, or structure–activity data—are unavailable. section 13.3.1

Its computational workflow combines:

  • More than 40 generative models run in parallel. section 13.3.1
  • Variational autoencoders represent chemical space continuously, while reinforcement learning searches that space. section 13.3.1
  • Multi-objective rewards balance predicted binding affinity, selectivity, solubility, CYP inhibition, and synthetic accessibility. section 13.3.1

Rentosertib design

For TNIK, Chemistry42 generated INS018_055 with GENTRL despite lacking known TNIK-selective compounds, a ligand-bound crystal structure, and prior structure–activity data. section 13.3.1

Figure 13.7 The four stages of the rentosertib program. Multi-omics data and literature flow through PandaOmics to a scored target list; Chemistry42 generates and optimizes candidates against a multi-objective reward; experimental readouts feed back to refine the models; clinical development follows. Sections 13.3.1 through 13.3.4 walk through each stage.

Trace how target analysis, molecular generation, experimental feedback, and clinical development connect in the rentosertib program. section 13.3.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Explains the generative workflow and reward objectives, but does not detail model training or experimental protocols.
Examples
Uses TNIK, rentosertib, and INS018_055 to illustrate candidate generation without established compounds or structure–activity data.
What it assumes
Requires a selected molecular target; the workflow supplies computational generation when known compounds, structures, and prior activity data are absent.
What you can do after
Evaluate generated molecules against affinity, selectivity, solubility, CYP inhibition, and synthesis-related objectives.
How it connects
Connects generative modeling, reinforcement learning, variational autoencoders, property prediction, and synthetic accessibility.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.